Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic Acid

Journal Article · · ChemMedChem
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; FOREIGN; National Institutes of Health (NIH)
OSTI ID:
1831264
Journal Information:
ChemMedChem, Vol. 16, Issue (19)
Country of Publication:
United States
Language:
ENGLISH

References (61)

The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network March 2007
Structural Insights into the Regulation of Hippo Signaling February 2017
The Biology of YAP/TAZ: Hippo Signaling and Beyond October 2014
Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity January 2001
Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin January 2011
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version May 2010
Emerging roles of TEAD transcription factors and its coactivators in cancers May 2013
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma November 2010
The Hippo Signaling Pathway in Development and Cancer October 2010
YAP and the Hippo pathway in pediatric cancer February 2017
Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse August 2016
YAP/TAZ for cancer therapy: Opportunities and challenges (Review) February 2015
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer November 2008
High Cancer-Specific Expression of Mesothelin ( MSLN ) Is Attributable to an Upstream Enhancer Containing a Transcription Enhancer Factor–Dependent MCAT Motif October 2007
Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial–mesenchymal transition and metastasis in a YAP-independent manner September 2015
Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer December 2013
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment December 2013
TEAD mediates YAP-dependent gene induction and growth control July 2008
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein January 2009
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals September 2007
YAP/TAZ at the Roots of Cancer June 2016
YAP/TAZ Activation as a Target for Treating Metastatic Cancer April 2018
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP June 2012
Structural insights into the YAP and TEAD complex February 2010
Targeting Hippo pathway by specific interruption of YAP‐TEAD interaction using cyclic YAP‐like peptides November 2014
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction July 2014
Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence August 2019
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets December 2017
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer February 2014
Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface May 2018
Antiproliferative and Antimigratory Effects of a Novel YAP–TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking January 2019
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex December 2020
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway February 2016
Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling January 2016
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ: TEAD Acylation November 2017
Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity May 2019
Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy November 2015
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling June 2020
TEAD–YAP Interaction Inhibitors and MDM2 Binders from DNA‐Encoded Indole‐Focused Ugi Peptidomimetics July 2020
Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors December 2019
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction March 2019
Identification of Quinolinols as Activators of TEAD-Dependent Transcription November 2019
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability September 2007
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination October 2006
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins August 2017
Structural Basis of Inhibitor Specificity of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM-1) Kinase October 2005
1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease March 2020
Current NMR Techniques for Structure-Based Drug Discovery January 2018
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects October 2018
Concentration Measurement by Proton NMR Using the ERETIC Method July 1999
NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions June 2015
Role of YAP/TAZ in mechanotransduction June 2011
Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2 July 2008
New N -Arachidonoylserotonin Analogues with Potential “Dual” Mechanism of Action against Pain November 2007
The preparation of 3-substituted-1,5-dibromopentanes as precursors to heteracyclohexanes January 2011
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography October 2014
Novel Flufenamic Acid Analogues as Inhibitors of Androgen Receptor Mediated Transcription August 2009
Pd II ‐Catalyzed Monoselective ortho Halogenation of CH Bonds Assisted by Counter Cations: A Complementary Method to Directed ortho  Lithiation June 2008
Synthesis and reactions of some 5(6)-(1-adamantyl)benzimidazoles August 2008
4-(1-Adamantyl)phenylalkylamines with Potential Antiproliferative Activity February 2016
A Supramolecular Microfluidic Optical Chemosensor February 2002

Similar Records

Related Subjects